No additional adverse event; HCP called to report a Temperature Excursion on case number 02740636. The case is still ongoing and it could not be confirmed if the products were still supported. The HCP reports that VARIVAX was inadvertently administered after suffering from a Te; This spontaneous report was received from Other Health Professional and refers to a. The patient’s medical history was not reported. The patient’s concurrent conditions included medication dilution. Concomitant medications included sterile diluent (MERCK STERILE DILUENT) (manufacturer unknown). On 06-DEC-2024, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5 milliliter, lot #Y006522, expiration date: 25-MAR-2026, administered for prophylaxis (strength, and route of administration were not provided). On an unknown date, the patient experienced No additional adverse event. On 06-DEC-2024, the patient experienced HCP called to report a Temperature Excursion on case number 02740636. The case is still ongoing and it could not be confirmed if the products were still supported. The HCP reports that VARIVAX was inadvertently administered after suffering from a Te. At the time of reporting, the outcome of the event HCP called to report a Temperature Excursion on case number 02740636. The case is still ongoing and it could not be confirmed if the products were still supported. The HCP reports that VARIVAX was inadvertently administered after suffering from a Te was not known, the outcome of the event No additional adverse event was not known. The action taken with VARIVAX regarding HCP called to report a Temperature Excursion on case number 02740636. The case is still ongoing and it could not be confirmed if the products were still supported. The HCP reports that VARIVAX was inadvertently administered after suffering from a Te was reported as Not Applicable. The action taken with VARIVAX regarding No additional adverse event was reported as Not Applicable.